Device Week, 6 November 2020 – Q3 Earnings Results; USPSTF Recommendations Lowers Colon Screening Age
Executive Summary
On this week’s podcast, Medtech Insight managing editor Marion Webb discusses how the US Preventive Services Task Force’s recommendations to lower colon screening to age 45 may impact sales of Exact Sciences’ Cologuard stool test, and deputy editor Reed Miller highlights third-quarter results of Stryker, Boston Science and Edwards Lifesciences.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode: